Johns Hopkins Team Develops Gel Delivery Method to Keep Colorectal Cancer Therapy Localized
核心洞察
A Johns Hopkins University (搜索) research team led by Dr. Aleksander S. Popel developed an experimental therapy to destroy colorectal cancer (搜索) cells but found the drug spilled into healthy tissue when injected directly into tumors.
Colorectal Cancer Alliance (搜索) funding through Project Cure CRC supported development and testing of three new delivery methods, with a gel identified as the most promising solution.
The gel can flow through a syringe and keep the treatment localized within the tumor while releasing it over time, though the work remains early and conducted only in the lab.
A Johns Hopkins University (搜索) research team led by Dr. Aleksander S. Popel encountered a significant obstacle while developing an experimental therapy designed to destroy colorectal cancer (搜索) cells: they could not keep the cancer-killing drug focused on the cancer. When injected directly into a tumor, the drug was spilling into healthy tissue, limiting its therapeutic potential.
The challenge was described by Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance (搜索), who shared the development on LinkedIn: "A CRC research team was plagued by a tough issue: They couldn't keep the cancer-killing drug they've developed focused on the cancer."
A Gel-Based Delivery Solution
Funding from the Colorectal Cancer Alliance (搜索) through Project Cure CRC enabled the team to develop and test three new delivery methods to address the localization problem. Among these approaches, the researchers ultimately identified a gel as the most promising solution. The gel could flow through a syringe and then help keep the treatment localized within the tumor while releasing it over time.
This delivery strategy directly addresses the core limitation of the experimental therapy, which had shown promise but was undermined by its tendency to diffuse into surrounding healthy tissue.
Early-Stage Status and Clinical Potential
The work remains early and has been conducted in the laboratory. However, the potential is described as exciting. The team is exploring whether this approach could eventually be used in people with rectal cancer (搜索) in the weeks before surgery to reduce tumors. The hope is that it could one day make some tumors operable or allow for less extensive surgery.
Sapienza emphasized the iterative nature of the research process: "Science does not always move in a straight line. Researchers encounter problems, test new approaches, learn what works and what doesn't, and keep moving forward. Funding gives them the ability to do that."
The Role of Research Investment
There is still a long road ahead before this research can reach patients, a reality that underscores why continued research investment is critical. The Colorectal Cancer Alliance (搜索) expressed pride in supporting researchers who are "taking on difficult problems and pursuing new possibilities for people with colorectal cancer (搜索)."
Sapienza concluded with a call for continued support: "We need more research. We need more investment. And we need to keep pushing toward better treatment options and better outcomes for people facing this disease."